2013 Rosenfeld Cancer Center One of 79 Nationwide to Earn Oncology Quality Award
The Commission on Cancer (CoC) of the American College of Surgeons (ACS) has granted a 2012 Outstanding Achievement Award to The Rosenfeld Cancer Center at Abington Memorial Hospital, one of only 79 cancer programs in the U.S. to earn this award and one of only three in Pennsylvania. Award criteria were based on qualitative and quantitative surveys conducted last year.
The CoC Outstanding Achievement Award (OAA) is designed to recognize cancer treatment programs that strive for excellence in providing quality care to cancer patients. A facility receives this award following the on-site evaluation by a physician surveyor during which the facility demonstrates a Commendation level of compliance with seven standards that represent the full scope of the cancer program. The facility must also receive a compliance rating for the remaining 29 standards.
2012 ACR-ASTRO Accreditation for Radiation Oncology
The Rosenfeld Cancer Center at Abington Memorial Hospital has been awarded a three-year term of accreditation in radiation oncology as the result of a recent review by the American College of Radiology (ACR) and The American Society for Radiation Oncology (ASTRO). Radiation oncology or radiation therapy is the careful use of high-energy radiation to treat cancer. A radiation oncologist uses radiation to cure cancer or to relieve a cancer patient’s pain.
The ACR-ASTRO seal of accreditation represents the highest level of quality and patient safety. It is awarded only to facilities meeting specific Practice Guidelines and Technical Standards developed by ACR and ASTRO after a peer-review evaluation by board-certified radiation oncologists and medical physicists who are experts in the field.
2010 Commission on Cancer Accreditation with Commendation
The Commission on Cancer (CoC) of the American College of Surgeons (ACoS) granted Three-Year Accreditation with Commendation to The Rosenfeld Cancer Center at AMH. The program has been accredited by the ACoS for 13 consecutive years.
The Rosenfeld Cancer Center at AMH received a Three-Year Accreditation with Commendation following the onsite evaluation by a physician surveyor during which the program demonstrated a commendation level of compliance with one or more standards that represent the full scope of the cancer program (cancer committee leadership, cancer data management, clinical services, research, community outreach, and quality improvement).
Established in 1922 by the American College of Surgeons, the CoC is a consortium of professional organizations dedicated to improving survival rates and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care. Its membership includes Fellows of the American College of Surgeons and 42 national organizations that reflect the full spectrum of cancer care.
2010 Breast Imaging Center of Excellence Designation
AMH's Mary T. Sachs Breast Center, located at the Abington Health Center - Schilling Campus, has been designated a Breast Imaging Center of Excellence by the American College of Radiology (ACR).
The ACR recognizes breast imaging centers that have earned accreditation in all of the College's voluntary, breast-imaging accreditation programs and modules, in addition to the mandatory Mammography Accreditation Program as Breast Imaging Centers of Excellence.
This designation means that breast imaging services at the Mary T. Sachs Breast Center are fully accredited in mammography, stereotactic breast biopsy, breast ultrasound and ultrasound-guided breast biopsy. Peer-reviewed evaluations, conducted in each breast imaging modality by board-certified physicians and medical physicists who are experts in the field, have determined that this facility has achieved high practice standards in image quality, personnel qualifications, facility equipment, quality control procedures, and quality assurance programs.
2009 NAPBC Breast Center Designation
The Rosenfeld Cancer Center at AMH has been granted a three-year/full accreditation designation by the National Accreditation Program for Breast Centers (NAPBC), a program administered by the American College of Surgeons. Accreditation by the NAPBC is given only to centers that have voluntarily committed to providing the highest level of quality breast care and that undergo a rigorous evaluation process and review of their performance.
During the survey process, the center must demonstrate compliance with standards established by the NAPBC for treating women with the full spectrum of treatments for breast disease. The standards include proficiency in the areas of center leadership, clinical management, research, community outreach, professional education and quality improvement. A breast center that achieves NAPBC accreditation has demonstrated a firm commitment to offer its patients every significant advantage in their battle against breast disease.
Receiving care at an NAPBC accredited center ensures that a patient will have access to: comprehensive care, including a full range of state-of-the-art services; a multidisciplinary team approach to coordinate the best treatment options; information about ongoing clinical trials and new treatment options; and quality breast care close to home.
2008 Blue Distinction Center for Complex and Rare Cancers
Independence Blue Cross selected Rosenfeld Cancer Center as one of the Delaware Valley's four Blue Distinction Centers for Complex and Rare CancersSM. The Rosenfeld Cancer Center received the designation for its comprehensive inpatient cancer care programs delivered by multidisciplinary teams with subspecialty training and distinguished clinical expertise in treating complex and rare cancers, as well as, for its major surgical treatments for these rare types of cancer.
Among other selection criteria, AMH met the following thresholds necessary to be named as a Blue Distinction Center for Complex and Rare Cancers for: depth of expertise across cancer disciplines in medicine, surgery, radiation oncology, pathology and radiology and has multidisciplinary team input, including sub-specialty trained teams for complex and rare cancers; ongoing quality management and improvement programs for cancer care; an ongoing commitment to using clinical data registries and providing access to appropriate clinical research for complex and rare cancers; and sufficient volume of experience in treating rare and complex cancers.
Complex and rare cancers comprise approximately 15 percent of new cancer cases each year, making it difficult for patients to locate or research facilities with oncologic or surgical teams that are experienced in this specialty. The Blue Distinction designation helps identify these institutions.